Physician

Aron Isaac Schwarcz, MD

According to 2025 Medicare claims, Aron Schwarcz, MD (NPI: 1881822518) practices interventional cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is MEDICAL ASSOCIATES OF ENGLEWOOD, PC (NPI: 1952681918; TIN: 452548322) and primary practice location at 07631-1808. Schwarcz is affiliated with the Englewood Health ACO, LLC (ACO ID: A5653), participating under the MSSP model.

Schwarcz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 615 traditional Medicare patients, billed 2,629 HCPCS/CPT codes, and received $221,634 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,911 prescription claims across 319 beneficiaries totaling $314,953 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 116 records totaling $52,989. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $46,764 to $314,953. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	940	3,173	$262,164
2016	871	2,721	$238,772
2017	856	2,989	$259,974
2018	661	2,519	$233,488
2019	687	2,328	$220,049
2020	613	2,006	$179,870
2021	610	2,113	$198,578
2022	664	2,338	$219,873
2023	613	2,166	$197,573
2024	615	2,629	$221,634

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	94	687	$46,764
2016	130	959	$91,564
2017	160	1,064	$143,328
2018	181	1,269	$126,877
2019	191	1,160	$158,043
2020	177	1,157	$156,966
2021	227	1,307	$166,958
2022	233	1,446	$249,703
2023	280	1,757	$351,394
2024	319	1,911	$314,953

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	237	440	$110
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	106	188	$105
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	164	168	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	245	477	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	228	388	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	121	7,775	$149,714
Xarelto	Rivaroxaban	41	2,910	$53,559
Entresto	Sacubitril/Valsartan	21	1,050	$23,121
Metoprolol Succinate	Metoprolol Succinate	180	15,601	$3,728
Amiodarone Hcl	Amiodarone Hcl	29	2,370	$2,393

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	108	$25,399	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	8	$27,590	Janssen Research & Development, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aron Isaac Schwarcz, MD?

Tedicare shows public-source Medicare data for Aron Isaac Schwarcz, MD (NPI 1881822518), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aron Isaac Schwarcz, MD have ACO affiliation data?

Aron Isaac Schwarcz, MD is shown with ACO affiliation data for Englewood Health ACO, LLC (MSSP, ACO ID A5653).

What billing organization is linked to Aron Isaac Schwarcz, MD?

Aron Isaac Schwarcz, MD is linked to MEDICAL ASSOCIATES OF ENGLEWOOD, PC (billing NPI 1952681918) in the available physician profile data.

Does Aron Isaac Schwarcz, MD have Open Payments data?

Aron Isaac Schwarcz, MD has 116 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.